Inari Medical (NARI) | Finance information

Compare Inari Medical

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Inari Medical Inc	-107.7	0%	-5%	5.9	-
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$50.00

Target Price by Analysts

6.4% upsideInari Medical Target Price Details

$-36.00

Current Fair Value

176.6% downside

Overvalued by 176.6% based on the discounted cash flow analysis.

Share Statistics

Market cap	$2.54 Billion
Enterprise Value	$2.44 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-0.41
Beta	0.58
Outstanding Shares	58,138,159
Avg 30 Day Volume	1,223,854

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-107.69
PEG	-10.86
Price to Sales	5.87
Price to Book Ratio	6.71
Enterprise Value to Revenue	4.69
Enterprise Value to EBIT	-145.47
Enterprise Value to Net Income	-104
Total Debt to Enterprise	0
Debt to Equity	0

Revenue Sources

No data

ESG Score

No data

About Inari Medical Inc

456 employees

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based...